Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CTRX
Show more
Clinical trial prescription services, namely, retail pharmacy services for use in providing patient access to pharmaceuticals and pharmaceutical supplies via a specialty pharmacy network; subscription-based order fulfillment services in the field of pharmaceutical drugs and supplies for clinical trial use
Class 35 – Advertising & retail
Status timeline
- 10 Jan 2022Application filedNew Application Entered
- 13 Oct 2022Assigned to an examining attorneyAssigned To Examiner
- 14 Oct 2022Approved for publicationApproved For Pub - Principal Register
- 22 Nov 2022Published for oppositionPublished For Opposition
- 17 Jan 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 8 Feb 2023Ownership assignment recordedAutomatic Update Of Assignment Of Ownership
- 17 Jul 2023Statement-of-use extension 1 grantedSou Extension 1 Granted
- 3 Jan 2024Statement of use filedTeas Statement Of Use Received
- 23 Jan 2024Statement of use acceptedAllowed Principal Register - Sou Accepted
- 24 Jan 2024Statement of use acceptedNotice Of Acceptance Of Statement Of Use E-Mailed
- 27 Feb 2024Registered on the Principal RegisterRegistered-Principal Register
All 25 events
| 2024-02-27 | Registered-Principal Register |
| 2024-02-27 | Notice Of Registration Confirmation Emailed |
| 2024-01-24 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2024-01-23 | Allowed Principal Register - Sou Accepted |
| 2024-01-22 | Case Assigned To Intent To Use Paralegal |
| 2024-01-22 | Statement Of Use Processing Complete |
| 2024-01-03 | Teas Statement Of Use Received |
| 2024-01-03 | Use Amendment Filed |
| 2023-07-19 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-07-17 | Sou Teas Extension Received |
| 2023-07-17 | Sou Extension 1 Filed |
| 2023-07-17 | Sou Extension 1 Granted |
| 2023-02-08 | Automatic Update Of Assignment Of Ownership |
| 2023-01-17 | Noa Mailed - Sou Required From Applicant |
| 2022-11-22 | Published For Opposition |
| 2022-11-22 | Official Gazette Publication Confirmation E-Mailed |
| 2022-11-02 | Notification Of Notice Of Publication E-Mailed |
| 2022-10-14 | Examiners Amendment -Written |
| 2022-10-14 | Examiners Amendment E-Mailed |
| 2022-10-14 | Notification Of Examiners Amendment E-Mailed |
| 2022-10-14 | Examiner's Amendment Entered |
| 2022-10-14 | Approved For Pub - Principal Register |
| 2022-10-13 | Assigned To Examiner |
| 2022-01-10 | New Application Entered |
| 2022-01-10 | New Application Office Supplied Data Entered |
Goods & services by class
Class 35 Advertising & retail
Clinical trial prescription services, namely, retail pharmacy services for use in providing patient access to pharmaceuticals and pharmaceutical supplies via a specialty pharmacy network; subscription-based order fulfillment services in the field of pharmaceutical drugs and supplies for clinical trial use
First use anywhere 0 Apr 2020 · First use in commerce 0 Nov 2020
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 27 Feb 2024; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.